Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluoroquinolone Restriction Ofr the Prevention of C. Difficile Infection (CDI)_the FIRST Trial

NCT03848689 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT03848689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03848689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluoroquinolone Restriction Ofr the Prevention of C. Difficile Infection (CDI)_the FIRST Trial
Lead sponsor
University of Wisconsin, Madison
Phase
Observational
Overall status
Completed
Start date
May 1, 2019
Completion date
May 31, 2024
Enrollment
5,871 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

c difficile colitis, clostridium difficile, clostridium difficile infection